| Name | 3-Bromomethcathinone |
|---|
| Formal Name | 1-(3-bromophenyl)-2-(methylamino)-1-propanone, monohydrochloride |
|---|
| SMILES | O=C(C(NC)C)C1=CC(Br)=CC=C1.Cl |
|---|
| InChI Key | HNHVECYNAJJZIQ-UHFFFAOYSA-N |
|---|
| InChI Code | InChI=1S/C10H12BrNO.ClH/c1-7(12-2)10(13)8-4-3-5-9(11)6-8;/h3-7,12H,1-2H3;1H |
|---|
| Description | 3-Bromomethcathinone (3-BMC) is one of many designer synthetic cathinones that has been sold on the illicit drug market.1 3-BMC is structurally related to US regulated Schedule I controlled substance methcathinone (DEA #1237). The only difference between the two compounds is that 3-BMC has a bromine in the meta position on the phenyl ring. It has been published that 3-BMC acts as serotonin and norepinephedrine reuptake inhibitors. |
|---|
Status |
Verified |
|---|
| Submitted | 2014-11-17 |
|---|
| Submitted By | Cayman Chemical
Miami Valley Regional Crime Laboratory, Dayton, Ohio |
|---|
| Published | 2015-02-13 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the 3-Bromomethcathinone Monograph |
|---|
|
|
